AFTER 25th_BEF
> ATTENDEES​​
> INVESTORS
> PRESENTERS​​
> EXHIBITORS​​
> SPONSORS​​
> SUPPORTERS​​
3B Future Health Ventures
4BIO Capital
7G BioVentures
AAA Family Office
AATec Medical GmbH
AbbVie Ventures
AbbVie, Inc.
abcDNA GmbH
Ability Pharmaceuticals SA
Accequa
AdBio Partners
AdCab (under University of Helsinki)
Adularia AG
AFK & Partners Asset Management LLC
AION Labs
Aixial Group
Alder Therapeutics AB
AlgenScribe SAS
Algiax Pharmaceuticals GmbH
Alkapharmics SARL
Allegro N.V.
Allele Capital Partners, LLC
ALSA Ventures
AltamarCAM Partners
Alzheimer's Drug Discovery Foundation
AM-Pharma B.V.
Ampleia
Amporin Pharmaceuticals AG
AMR Action Fund GP GmbH
Anaveon AG
Andera Partners SA
Angelini Ventures S.p.A.
APR Applied Pharma Research s.a.
ARCHIMED
Arcinova
ARENSIA Exploratory Medicine
Arivin Therapeutics Ltd.
Arphamid Therapeutics SAS
ARTCLINE GmbH
Ascension
Asian Innovation and Finance Center (AIFC)
Asklepios Advisors
Astr Partners
AstraZeneca
AurorA Science Srl
Avance Life Sciences
AVANTECA Partners AG
Awen GmbH
Baker McKenzie
BaseLaunch
Bayer AG
BB Biotech
Bellevue Asset Management AG
BeOne Medicines I GmbH
Bergmann zur Hausen & Cie. GmbH
Berlin Institute of Health at Charité (BIH)
BERNINA BioInvest Ltd.
BIOCELL LTD.
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
BioEridan
BioGeneration Ventures
BioInnovation Institute
BioMedPartners AG
BioMedVC AG
Biopôle SA
Bioqube Ventures
BIOSTART Consulting GmbH
biotx.ai GmbH
BioXconomy
BirchBioMed Inc.
BlackRock
Bloomberg Intelligence
Bloomberg L.P.
Boehringer Ingelheim International GmbH
Boehringer Ingelheim Venture Fund GmbH
BOHE Angel Fund
Bootstrap Europe
Boyden Global Executive Search AG
Bpifrance
Bradley Woods & Co. Ltd
Brenus Pharma
Breslin AG
Brutkasten GmbH / VentureCapital Magazin
Business Angels Switzerland
Caedo Oncology
Cancer Research Horizons
Canton of Basel-Stadt
Capital Grand Est
CDP Venture Capital SGR S.p.A.
CDR-Life AG
Cereno Scientific AB
Chromos Labs
Chugai Venture Fund, LLC
CIS BIOPHARMA AG
Claris Ventures
ClavystBio
ClearideBio AG
CNS Pharmaceuticals, Inc.
Cohesion Bureau
Corinthian Financial Management SARL
Coulter Partners
Covington & Burling LLP
CPTx GmbH
Criteria Bio Ventures
Cube Labs SpA
Cue Biopharma, Inc.
Cukierman & Co. Life Sciences
Cullgen Inc.
Curlim
Cytora
Davis Polk & Wardwell LLP
DCRM Sciences, Inc.
DCVC Bio
DeBere Capital Partners
Debiopharm International SA
Delin Ventures
Desitin Arzneimittel GmbH
Diamante Società Benefit Srl
Digital Networks PLC
Dimericon Therapeutics AG
Disco Pharmaceuticals GmbH
docdok.health Ltd.
Droia Ventures
Eight Bridges
EIT Health e.V.
Elaia Partners
eleva GmbH
Eli Lilly and Company
Eliraz Ventures
Endeavor Venture Fund
Engimmune Therapeutics AG
ESC Advisors
European Investment Fund
Evernow Publishing Ltd, publisher of MedNous
Evidenze
ExcellGene SA
F. Hoffmann-La Roche AG
FatiAbGen International GmbH
Finanz und Wirtschaft
Fine Treatment Limited
FINNCURE Ltd.
Flerie
Fontaine Capital
Forbion
Forty51 Ventures AG
FoRx Therapeutics AG
Fountain Healthcare Partners
FreeMind Group
Fund+
FundaMental Pharma GmbH
Galimedix Therapeutics, Inc.
Genclis SA
Generation Fund Life Sciences Fund I
Genesis Capital
Genius Search GmbH & Co. KG
Genmab A/S
GETEC PARK.SWISS AG
GIBF
Gilde Healthcare Partners B.V.
Gimv
GL Capital Group
GordonMD Global Investments LP
Grabulovski Consulting Services GmbH
GrayBella Capital
GSK
H. Lundbeck A/S
H.C. Wainwright & Co., LLC
Hadasit Ltd.
HanchorBio Inc.
HBM Partners AG
HCRx
Heal Capital
Health Innovation Capital
HealthCap
HEPHAISTOS Pharma
Hercules Capital
High-Tech Gründerfonds Management GmbH
Hikma Ventures
Hoba Therapeutics ApS
Hong Kong Exchanges and Clearing Limited (HKEX)
Hong Kong Trade Development Council
i3 Partners GmbH
ICF Consult Switzerland
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Immunethep, S.A.
Indaco Venture Partners SGR S.p.A.
Industrifonden
InnoUp Farma
Innovestor Life Science Ltd.
Inotrem S.A.
Intermediate Capital Group PLC
InvestHK
IPF Partners
Ipsomel Innovations
Italian Angels for Growth (IAG)
JFG Life Sciences Stiftung der Universität Basel
JLP Health GmbH
JMI Capital Group
Johnson & Johnson Innovation LLC
Johnston Associates, Inc.
KBI Biopharma, Inc.
KdT Ventures
Kerna Ventures
KHAN Technology Transfer Fund
King Bioventures
KKR
Ksilink
Kurma Partners
Landmark Angels/Family Ofiice
Landmark BioVentures AG
Laverock Therapeutics Ltd.
Leads To Development
LifeCare Partners GmbH
LIfT BioSciences Ltd.
Limani Partners
LMU Munich
Loma Therapeutics
M&G Advisors GmbH
M2care
Macomics Ltd.
MC Services AG
Medicines Discovery Ventures
MEDiSTRAVA
Melio Bio
Memo Therapeutics AG
Merck KGaA, Darmstadt, Germany
Mergermarket
metaLead Therapeutics AG
Mid Atlantic Bio Angels
Mighto Therapeutics
Mirabaud & Cie SA
MitoRx Therapeutics Limited
Mitsubishi Tanabe Pharma America, Inc.
ModernVivo, Inc.
Modi VC
Montis Biosciences BV
MSD
MSQ Ventures
Nanolattix
NanoTherix
ND Capital
Neurochlore
New Science Fund
NG Bio Ltd
NLC Health Ventures
NodThera, Inc.
Nomal Therapeutics
NoToVir Srl
Nouscom AG
Novac BiotechBD
NovaQuest Capital Management, LLC
Novartis AG
Novartis Pharma AG
Novartis Venture Fund
Novo Holdings A/S
Novo Nordisk A/S
NRW.Bank
NxR Biotechnologies GmbH
Octopus Ventures
Olgram SAS
OmnilinX Therapeutics AG
Ona Therapeutics
Oncode Accelerator
Oncomatryx Biopharma S.L.
Oncovita
Onena Medicines AG
OphthaNova Therapeutics AG
Oppenheimer & Co. Inc.
Origenis GmbH
Orikine Bio, S.L.
OrthoTreat
Oryzon Genomics, S.A.
Otsuka America Pharmaceutical, Inc.
Oxford Science Enterprises
OxSonics
Pace Ventures
palleos healthcare GmbH
Pappas Capital LLC
Pathios Therapeutics Limited
Perogative LLC
Perseo Pharma AG
Pharmaron UK Ltd
Pharmell Life Sciences SA
Pharming Group NV
Pilatus Biosciences SA
Platypus
Playground Global
Pleco Therapeutics BV
Pluvia Biotech
PMIC Advisors Group Ltd.
Primo Capital SGR S.p.A.
Procavea Biotech AG
Pureos Bioventures
Qiming Venture Partners
Qualified Capital
QuantHealth
Recordati Pharma GmbH
RedHill Biopharma Ltd.
remynd NV
Roche Diagnostics
Ropes & Gray LLP
Rosetta Capital Ltd.
RV Invest
Ryvu Therapeutics, S.A.
Salvina Therapeutics AG
Sanavia Oncology
Schwarz Financial Communication
SCI Ventures LLC
Scius Communications
Secarna Pharmaceuticals GmbH & Co. KG
Selvita S.A.
Sen-Jam Pharmaceutical
Senya Therapeutics
Seqens
Serca Pharmaceuticals AS
Serenatis Bio
Seroba Life Sciences
Seventure Partners
Sherpa Healthcare Partners
SILREAL GmbH
Simplexia AB
SixPeaks Bio AG
Sobi
Sofinnova Investments
SOTIO Biotech a.s.
Sound Bioventures Management AB
SPARK Finland
Staatz BD & Strategy
Staatz Business Development & Strategy
STALICLA SA
SternAegis Ventures
Stifel
Strategic Transactions Advisory AG
Stromal Therapeutics AG
Sunstone Life Science Ventures
Suterscience GmbH
Swiss Biotech Association
SWISS IMMUNE | Amedioo EDC
SynuCa Therapeutics
T-knife Therapeutics
Taiho Ventures, LLC
TargImmune Therapeutics AG
Teitur Trophics ApS
Telomere Therapeutics
Tessara Therapeutics Pty Ltd.
The Fulford Group Ltd.
TheraVenture GmbH
TiVentures SA
TOLREMO Therapeutics AG
TransCure bioServices SAS
Tridek-One Therapeutics
Turbine Ltd.
UBS AG
UCEA Family Office
Umlaut.bio GmbH
University of Basel Innovation Office
University of Szeged
University of Zurich
UPyTher B.V.
USI Startup Centre
V-Bio Ventures BV
Valor Management
Valpharma Group SpA
Vandria SA
Venture Valuation AG
Versant Ventures
Verve Ventures
Vesalius Biocapital IV Partners SàRL
Vesna Deeptech VC
VI Partners AG
VIB
Viopas Venture Consulting GmbH
Vogel BioC
VUS Genetics
WBB Securities, LLC
Wellington Partners
Worldwide Clinical Trials
XGen Venture SGR S.p.A.
Xlife Sciences AG
XOventure GmbH
YAYA Capital
Ysios Capital
Zinc VC
Last updated on: 16th of October